newsfilter
← Latest News
GlobeNewswire·

AIM ImmunoTech to Present at the Virtual Investor Long COVID Event

OCALA, Fla., Sept. 21, 2022 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE:AMERICAN) ("AIM" or the "Company"), an immuno-pharma company focused on the research and development of therapeutics to treat multiple types of cancers, immune disorders, and vir